Nuvation Bio Gains FDA Fast Track for Safusidenib
New York, New York, August 20, 2026 Nuvation Bio Inc. has announced that the U.S. Food and Drug Administration...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
New York, New York, August 20, 2026 Nuvation Bio Inc. has announced that the U.S. Food and Drug Administration...
Silver Spring, Maryland, August 19, 2026 The U.S. Food and Drug Administration (FDA) has authorized Aletta, a first-of-its-kind standalone...
Silver Spring, Maryland, August 18, 2026 The U.S. Food and Drug Administration (FDA) has issued a new discussion paper...
DULUTH, Georgia, August 12, 2026 Bridge to Life Ltd., a medical technology company specializing in organ preservation and perfusion...
INDIANAPOLIS, Indiana, August 12, 2026 Eli Lilly and Company has intensified its efforts to combat the illegal sale of...
New York, August 6, 2026 WindRose Health Investors, LLC has completed the recapitalization of Verified Clinical Trials, LLC (VCT),...
Atlanta, Georgia, August 5, 2026 UCB has announced the publication of a post hoc analysis in Epilepsia Open demonstrating...
Bagsværd, Denmark, August 5, 2026 Novo Nordisk has secured a significant legal victory after the District Court of The...
Aurora, Colorado, August 3, 2026 A University of Colorado Anschutz Medical Campus-led multicenter clinical trial has demonstrated that an...
WASHINGTON, July 17, 2026 The American Pharmacists Association (APhA) has called on the U.S. Food and Drug Administration (FDA)...
